scispace - formally typeset
L

Lisa B. Dixon

Researcher at Columbia University

Publications -  377
Citations -  16357

Lisa B. Dixon is an academic researcher from Columbia University. The author has contributed to research in topics: Mental health & Mental illness. The author has an hindex of 56, co-authored 324 publications receiving 14703 citations. Previous affiliations of Lisa B. Dixon include University of Maryland, Baltimore & Capital District Health Authority.

Papers
More filters
Journal ArticleDOI

The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003

TL;DR: Evidence points to the value of treatment approaches combining medications with psychosocial treatments, including psychological interventions, family interventions, supported employment, assertive community treatment, and skills training.
Journal ArticleDOI

Implementing evidence-based practices in routine mental health service settings.

TL;DR: The authors discuss common concerns about the use of evidence-based practices, such as whether ethical values have a role in shaping such practices and how to deal with clinical situations for which no scientific evidence exists.
Journal ArticleDOI

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

TL;DR: Recommendations for addressing adherence problems to improve patient outcomes are developed, noting that multiple problems may be involved, requiring a combination of interventions.
Journal ArticleDOI

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

TL;DR: Schizophrenic patients who abuse drugs may represent a subgroup of patients with better prognoses and less severe clinical characteristics of schizophrenia, but their drug abuse may adversely affect global outcome.
Journal ArticleDOI

Prevalence and Correlates of Diabetes in National Schizophrenia Samples

TL;DR: This study of diabetes in the early 1990s suggests that even before the widespread use of the atypical antipsychotic drugs, diabetes was a major problem for persons with schizophrenia.